Clinical Trials Sponsored by jonas johnson

Total 5145 results

Jonas Johnson

Terminated

Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy

Dysphagia | Oral Pharyngeal Cancer

United States
Jonas Johnson
TJA Health, LLC

Completed

Blinded Dry Mouth Spray Crossover Study

Head and Neck Cancer | Xerostomia | Xerostomia Following Radiotherapy

United States
Jonas Malmstedt

Completed

HRQoL Among Patients Amputated Due to Peripheral Arterial Disease

Quality of Life | Peripheral Arterial Disease | Amputation | Prosthesis User

Sweden
Oliver Jonas, PhD

Recruiting

Implantable Microdevice In Primary Brain Tumors

Glioblastoma | Astrocytoma | Anaplastic Oligodendroglioma | Anaplastic Astrocytoma of Brain | Grade III Glioma | Grade IV Glioma | Grade II Glioma | Oligodendroglioma of Brain

United States
The Jones Institute

Unknown

Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales

Postpartum Depressive Mood | Postpartum Sexual Function

United States
Johnson & Johnson Vision Care, Inc.
Johnson & Johnson

Terminated

Silicone Hydrogel Contact Lenses on Low Astigmatism in Japan

Refractive Error | Astigmatism | Myopia

Japan
Oliver Jonas
Massachusetts General Hospital

Completed

Microdevice for Evaluating Drug Response in Site in Lung Lesions

Lung Cancer | Lung Tumor

United States
AstraZeneca
Johnson & Johnson

Completed

Phase III Study of ICI35,868 (Diprivan) With and Without EES0000645/A (SDS) on Gastrointestinal Endoscopy (Kagami_SDS)

Sedation to be Moderate for a Diagnostic Gastrointestinal Endoscopy and Gastrointestinal Endoscopic Polypectomy

Japan
Brian Jonas
Pharmacyclics LLC.

Completed

Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome

Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Refractory Anemia With Excess Blasts in Transformation

United States
AdventHealth
Johnson & Johnson

Completed

Resilience Intervention for Critical Care Nurses

Stress

United States
Johnson & Johnson Pte Ltd
Johnson & Johnson (Hong Kong) Ltd.

Completed

PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region

Pneumonia | Urinary Tract Infections | Pneumonia, Ventilator-Associated

Malaysia, Singapore, Vietnam, Indonesia, Hong Kong
Jenny Jones

Completed

Bifocal & Atropine in Myopia (BAM) Study (BAM)

Refractive Errors
Bayne-Jones Army Community Hospital

Withdrawn

Results From a 24 Week Trial of EMDR Combined With Venlafaxine XR (EMDRVEN)

Posttraumatic Stress Disorder
Johns Hopkins University
Robert Wood Johnson Foundation

Completed

Randomized Trial to Evaluate the Effectiveness of Nurse Case Management

Hypertension | Type 2 Diabetes | Preterm Delivery | Gestational Diabetes

United States
Johnson & Johnson Private Limited

Completed

A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes

Diabetes Mellitus

India
Johnson & Johnson Private Limited

Completed

A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis

Arthritis, Psoriatic | Spondylitis, Ankylosing

India
Johnson & Johnson Private Limited

Withdrawn

A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer

Prostate Cancer

India
Johnson & Johnson Private Limited

Completed

A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting

Diabetes Mellitus, Type 2

India
Johnson & Johnson Medical, China

Completed

Health Economics Evaluation of Catheter Ablation Versus Drug Therapy in Atrial Fibrillation (AF) in China

Atrial Fibrillation
DePuy International
Johnson & Johnson

Terminated

Multi-centre Study to Assess Long-term Safety and Efficacy of the Silent™ Hip Prosthesis in Primary THR

Osteoarthritis

United Kingdom, Australia, France, Germany, Italy
Johnson & Johnson Taiwan Ltd

Terminated

A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia

Schizophrenia

Taiwan
Dermatrials Research
Johnson & Johnson

Completed

Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin

Acne

Canada
Johnson & Johnson Taiwan Ltd

Terminated

An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)

Pain | Spondylitis, Ankylosing
Johnson & Johnson Taiwan Ltd

Completed

A Study on Behavioral and Psychological Symptoms of Dementia

Dementia
Johnson & Johnson Taiwan Ltd

Completed

Observational Study on the Patients With Pain Medications

Pain
Johnson & Johnson Taiwan Ltd

Completed

An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia

Schizophrenia
Johnson & Johnson Taiwan Ltd

Completed

First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical Patients (TEAMS)

Epilepsy
Johnson & Johnson Medical, China

Terminated

A Registration Study to Evaluate the Performance of CHIRON® RIBA® HCV 3.0 SIA in HCV Antibody Detection

Hepatitis C

China
Johnson & Johnson Medical, China

Completed

Surgiscreen Registration

Irregular Antibody Screening

China
Johnson & Johnson Pte Ltd

Completed

A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy

Epilepsy
Johnson & Johnson Pte Ltd

Completed

The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy

Sexual Dysfunction, Physiological

Korea, Republic of, Australia, Thailand
Johnson & Johnson Taiwan Ltd

Completed

Fentanyl for Treatment Pain Caused by Radiotherapy

Pain
Johns Hopkins University
Robert Wood Johnson Foundation

Completed

A Fighting Chance: Pilot Study of a Group Mentoring Intervention for Assault Injured Youth

Violence

United States
Johns Hopkins University
Robert Wood Johnson Foundation

Completed

Stop Community MRSA Colonization Among Patients (SUSTAIN)

MRSA

United States
Johnson & Johnson Private Limited

Completed

A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion

Lymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-Cell

India
Johnson & Johnson Medical, China

Completed

China CellSearch Study

Metastatic Breast Cancer | Benign Breast Disease

China
Johnson & Johnson Pte Ltd

Completed

A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries (MARCOPOLO)

Plaque Psoriasis

Taiwan, Korea, Republic of, Malaysia, Singapore, Indonesia
Johnson & Johnson Taiwan Ltd

Completed

Pain Satisfaction Survey

Pain
Johnson & Johnson Taiwan Ltd

Completed

Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone

Schizophrenia | Schizoaffective Disorder
Johnson & Johnson Taiwan Ltd

Completed

Study on Migraine and Headache in Epileptic Patients

Epilepsy
Johnson & Johnson Taiwan Ltd

Completed

Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)

Schizophrenia
Johnson & Johnson Taiwan Ltd

Terminated

A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain

Cancer Pain
Johnson & Johnson Taiwan Ltd

Completed

A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma

Multiple Myeloma
Johnson & Johnson Taiwan Ltd

Completed

An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients

Pain
Johnson & Johnson Taiwan Ltd

Completed

A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder
Vita Care
Johnson & Johnson

Recruiting

ACL Reconstruction With Simple and Double Bundle Technique Using Two Different Implants for Graft Fixation

Knee Injuries | ACL Injury | Sports Injury | ACL Tear

Brazil
Johnson & Johnson Medical, China

Completed

OneTouch® Verio™Pro+ Blood Glucose Monitoring System Clinical Accuracy Study in China

Blood Glucose Measurement

China
Johnson & Johnson Private Limited

Completed

A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent

Multiple Myeloma

India
Johnson & Johnson Pte Ltd

Terminated

A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (RISE)

Human Immunodeficiency Virus Infections

India
Austin Eye
Johnson & Johnson

Completed

Symfony Intraocular Lens Retrospective Chart Review

Cataract

3

Subscribe